Soterios Pharma completes Phase II enrolment for STS-01 in mild / moderate (patchy) alopecia areata

Soterios Pharma, a privately held clinical-stage pharmaceutical company, announced today that it has completed target enrolment for its Phase II trial with STS-01 for mild / moderate (patchy) alopecia areata.  Final results of the study are anticipated to be available in Q2 2024. David Fleet, CEO of Soterios Pharma, said, “This represents an important milestone in […]

thaipr.net

1 พ.ย. 66

Possibilities and Opportunities: Seminar held in Hong Kong about ETF Connect in China Allocation

Since the establishment of ETF Connect scheme in July 2022, the connection of Mainland China and Hong Kong capital markets was further strengthened. As of October 25th this year, the number of ETFs offered through the scheme grew over 130 and the total northbound cumulative trading volume reached over US$12 billion, demonstrating the favor of ETFs as […]

thaipr.net

1 พ.ย. 66
1 1,140 1,141 1,142 1,143 1,144 3,343